Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US8324367B2 · kind B2 · utility
9Cited by
57References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2009 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Oct 16, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compositions, methods and kits for regulation of gene therapies for Huntington's Disease, including, without limitation, reversible gene therapies and allele-specific therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.